Sara Ng: Moving Beyond Management to Stewardship – “Advancing Anticoagulation Stewardship” Released by NQF
Sara Ng, Clinical and Laboratory Haematologist, Director of Thrombosis and Haemostasis at South Western Sydney Local Health District, shared a post by Anticoagulation Forum on LinkedIn:
“Moving Beyond “Management” to “Stewardship”
Anticoagulants are life-saving, but they remain a top cause of adverse drug events. It’s time to upgrade our approach. The Joint Commission and the National Quality Forum (NQF) have released “Advancing Anticoagulation Stewardship: A Playbook.” This isn’t just about meeting National Patient Safety Goals — It is about building a resilient system that proactively prevents harm.
The 7 Core Elements of a Stewardship Program –
To truly protect our patients, we need to implement these foundational pillars:
1. Leadership Commitment: Securing resources (human, financial, tech) is the non-negotiable first step.
2. Accountability and Expertise: Appoint a single leader responsible for outcomes, supported by clinicians with deep hemostasis expertise.
3. Multidisciplinary Support: Break the silos. Pharmacy, Nursing, Hematology, and IT must work as one unit.
4. Data Tracking: You can’t fix what you don’t measure. Track performance, adverse events, and adherence to guidelines.
5. Systematic Care: Implement evidence-based protocols that are sustainable and standardized across the system.
6. Transitions of Care: The danger zone. Create robust safety nets for patients moving between hospital and home.
7. Education: Ensure every stakeholder—from the prescribing resident to the patient—understands the “why” and “how” of their therapy.
Why This Matters
We often focus on the drug (dosing, monitoring). Stewardship focuses on the system. By addressing barriers like limited data or fragmented communication, we can significantly reduce the risk of bleeding and thrombosis.”
Quoting Anticoagulation Forum‘s post:
“We are proud to have partnered with the National Quality Forum (NQF) on this important resource. It remains a valuable guide for organizations worldwide working to improve patient safety and implement evidence-based stewardship practices.
Explore the report here.”
More posts from Sara Ng on Hemostasis Today.
-
Oct 7, 2026, 16:44Amor Salah: 2026 NCS/SCCM Guidelines for Managing Antithrombotic-Associated ICH
-
Oct 7, 2026, 16:04NETs in Thrombosis: From Mechanism to Therapeutic Target
-
Oct 7, 2026, 15:28Amir Samimi: Prognostic Value of Platelet Count in Resected HNSCC
-
Oct 7, 2026, 15:21Eloïse Laouenan: Bridging Immunity and Thrombosis in MVTE
-
Oct 7, 2026, 15:10Uthra Sundaram: Honouring Donors During International Plasma Awareness Week
-
Oct 7, 2026, 15:04Daniel Victor Ortigoza: Should Frail Older Patients With AF Switch From VKA to DOACs?
-
Oct 7, 2026, 14:53Susan Noone: Donor Turned Recipient Shares Lifesaving Transfusion Story
-
Oct 7, 2026, 14:49Aimee Burtenshaw: The Impact of the Infected Blood Inquiry on Hospital Transfusion Laboratories
-
Oct 7, 2026, 14:41Vikash Jaiswal: Does Timing Matter for Calcium in Pre-Eclampsia Prevention?